Deloitte: Infographic – Measuring the return from Pharmaceutical innovation 2013

Major challenges in pharmaceutical innovation include diminishing returns in R&D investment from top-tier companies. The infographic below illustrates some of the factors leading to increasing costs of launching new products in a highly regulated environment.

Measuring the return from Pharmaceutical innovation 2013

Deloitte UK Centre for Health Solutions presents the Measuring the return from Pharmaceutical innovation 2013

Healthcare Recruiters International
Right Menu Icon